For Business Use Only. Does Not Ship to Residential Addresses. For use inside an Analyzer, Sold Separately.
Immunalysis 618UR-0100 SEFRIA Fentanyl Reagent, 100mL
Product Code: 618UR-0100
Manufacturer: Immunalysis Corporation
Shipping Weight: 2.00lbs (0.91kg)
Immunalysis 618UR-0100 SEFRIA Fentanyl Reagent, 100mL
SEFRIA™ reagents comprise the next generation immunoassay utilizing β-galactosidase enzyme allowing for lower cutoffs, wider assay span, and enhanced precision in a ready-to-use liquid format.
Our SEFRIA™ Fentanyl is the first-ever FDA 510(k) cleared assay designed for qualitative testing at a 1 ng/mL cutoff.
- High sensitivity
- Liquid stable and ready to use
- Designed for use on chemistry analyzers
Fentanyl is a synthetic narcotic analgesic of high potency and short duration of action. The drug is available as a citrate salt in an injectable solution containing 50 μg/mL. It is also available as a transdermal patch containing 2.5–10 mg fentanyl and provides a dose of 25–100 μg/hr for 72 hours for management of chronic pain.2
While fentanyl has all the properties of morphine, it is structurally different and therefore cannot be detected by screening tests for morphine and related opiates.
Administration: Intravenous, transdermal patch, flavored lozenges, lollipop, buccal tablets, nasal spray, and inhalant.
The Immunalysis® Fentanyl Urine SEFRIA™ Drug Screening Kit detects the presence of fentanyl and its major metabolites in human urine samples with a cutoff of 1 ng/mL for qualitative testing. In clinical performance studies, testing with the Fentanyl Urine SEFRIA™ Drug Screening Kit compared favorably to liquid chromatography-mass spectrometry (LC-MS) analysis in both sensitivity (identification of positive results) and specificity (identification of negative results).